Epstein Correspondence Discussing Fundraising and LP Sourcing for a Biotech Venture

Epstein Correspondence Discussing Fundraising and LP Sourcing for a Biotech Venture The email chain shows Jeffrey Epstein directly communicating with a fund manager (Boris Nikolic) about securing limited partners for a biotech fund, indicating Epstein's involvement in venture financing. While the content is vague and lacks specific names or amounts, it provides a concrete lead to investigate Epstein's role in capital flows to biotech startups, which could reveal undisclosed financial relationships. The novelty is moderate, as Epstein's investment activities have been reported, but specific fund details and LP pipelines are new. Key insights: Epstein ([email protected]) is being asked to provide potential LP contacts for a biotech fund.; The fund manager references a 'Biomatics Pitch Deck' attached to the email.; All current LPs are described as 'AAA+' and there is a pipeline of eight companies.